Fig. 5.
![Fig. 5. PP14.Fcγ1 increases OKT3 dose required for T-cell activation. / Purified T cells were stimulated with increasing amounts of solid-phase OKT3 mAbs either alone (♦), in conjunction with anti-CD28 mAb (▪), in conjunction with anti-CD28 mAb plus AF (12.5% vol/vol; ■), or in conjunction with anti-CD28 mAb plus purified PP14 · Fcγ1 (48 μg/mL; ▵). [3H]-thymidine incorporation was determined 72 hours later as described in the legend for Figure 1. Comparable results were obtained in 3 experiments.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/98/13/10.1182_blood.v98.13.3727/6/h82411873005.jpeg?Expires=1735555652&Signature=azqPNmf1HT7Eztl0Zh6-apmb0~kJw-NdsjrpvlyPPaAJniBrJft0ilWQ1bWM7UeiKr6BgS8M8D4WkLqWOosLIr4rs6GV3fs6q-Ib-uwuNRocVLNrP-n2sDQAMy1rZAiWFHQkOWaKzKqv~xyaIxDXhQ~tJ5dsjIHbOOagkHxMZjToF6j-LUD8BDNn24tSsKKx2Sj99FggRCRN754YTqk~WyDkblCccjUWduEZMdOFWjsX-KOxlJgHGrNm42YGE~1zDVRvzx99qM5-6iYnos3GUToX7J3nxG0WZKF3NHwJnMCxuSsAdo5WZUI6bWhJbi0Ex40hVnpm12Kjr3XC2NcBJw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
PP14.Fcγ1 increases OKT3 dose required for T-cell activation.
Purified T cells were stimulated with increasing amounts of solid-phase OKT3 mAbs either alone (♦), in conjunction with anti-CD28 mAb (▪), in conjunction with anti-CD28 mAb plus AF (12.5% vol/vol; ■), or in conjunction with anti-CD28 mAb plus purified PP14 · Fcγ1 (48 μg/mL; ▵). [3H]-thymidine incorporation was determined 72 hours later as described in the legend for Figure 1. Comparable results were obtained in 3 experiments.
